Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $33.97M | $28.21M | +20.41% |
Cost of Revenue | $41.99M | $20.36M | +106.19% |
Operating Income | $-367.6M | $-196.88M | -86.71% |
Net Income | $-374.38M | $-188.91M | -98.18% |
EPS (Basic) | $-0.91 | $-0.79 | -15.19% |
EPS (Diluted) | $-0.91 | $-0.79 | -15.19% |
R&D Expense | $258.27M | $141.49M | +82.54% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.3B | $775.86M | +67.86% |
Current Assets | $587.16M | $522.38M | +12.40% |
Total Liabilities | $383.21M | $191.41M | +100.20% |
Current Liabilities | $164.03M | $86.08M | +90.54% |
Stockholders' Equity | $919.15M | $584.45M | +57.27% |
Cash & Equivalents | $525.11M | $474.34M | +10.70% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-208.38M | $-184.52M | -12.93% |
Investing Cash Flow | $-13.08M | $-10.84M | -20.70% |
Financing Cash Flow | $138.19M | $277.02M | -50.12% |
D&A | $43.18M | $16.34M | +164.18% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -1082.2% | -697.9% | -384.29% |
Net Margin | -1102.2% | — | — |
ROE | -40.7% | — | — |
ROA | -28.7% | — | — |
Current Ratio | $3.58 | — | — |
Debt to Equity | $0.417 | — | — |
Other companies in Biotechnology